EUR 1.35
(-12.65%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 86.53 Million EUR | 219.12% |
2022 | 25.65 Million EUR | -38.77% |
2021 | 41.89 Million EUR | 1671.68% |
2020 | 2.36 Million EUR | 215.01% |
2019 | 750.75 Thousand EUR | -90.89% |
2018 | 8.24 Million EUR | -0.48% |
2017 | 8.28 Million EUR | 27.21% |
2016 | 6.5 Million EUR | 61.26% |
2015 | 4.03 Million EUR | 57.58% |
2014 | 2.56 Million EUR | 9.26% |
2013 | 2.34 Million EUR | 26.58% |
2012 | 1.85 Million EUR | 146.49% |
2011 | 751.42 Thousand EUR | 22.46% |
2010 | 613.63 Thousand EUR | 42.9% |
2009 | 429.42 Thousand EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 500 Thousand EUR | 0.0% |
2023 Q4 | 63.06 Million EUR | 0.0% |
2023 FY | 81.87 Million EUR | 219.12% |
2023 Q2 | 7.5 Million EUR | 0.0% |
2022 Q2 | 12.75 Million EUR | 0.0% |
2022 FY | 25.65 Million EUR | -38.77% |
2022 Q4 | 12.89 Million EUR | 0.0% |
2021 FY | 41.89 Million EUR | 1671.68% |
2021 Q4 | 13.34 Million EUR | 0.0% |
2021 Q2 | 28.55 Million EUR | 0.0% |
2020 FY | 2.36 Million EUR | 215.01% |
2020 Q4 | -1.54 Million EUR | 0.0% |
2020 Q2 | 3.91 Million EUR | 0.0% |
2019 FY | 750.75 Thousand EUR | -90.89% |
2019 Q2 | 484.32 Thousand EUR | 0.0% |
2019 Q4 | 266.24 Thousand EUR | 0.0% |
2018 Q4 | 3.94 Million EUR | 0.0% |
2018 Q2 | 4.29 Million EUR | 0.0% |
2018 FY | 8.24 Million EUR | -0.48% |
2017 Q4 | 4.8 Million EUR | 0.0% |
2017 FY | 8.28 Million EUR | 27.21% |
2017 Q2 | 3.47 Million EUR | 0.0% |
2016 Q2 | 1.64 Million EUR | 0.0% |
2016 Q4 | 4.86 Million EUR | 0.0% |
2016 FY | 6.5 Million EUR | 61.26% |
2015 FY | 4.03 Million EUR | 57.58% |
2015 Q2 | 969.73 Thousand EUR | 0.0% |
2015 Q4 | 3.06 Million EUR | 0.0% |
2014 Q2 | 834.64 Thousand EUR | 0.0% |
2014 FY | 2.56 Million EUR | 9.26% |
2014 Q4 | 1.72 Million EUR | 0.0% |
2013 Q1 | 355.1 Thousand EUR | 0.0% |
2013 FY | 2.34 Million EUR | 26.58% |
2013 Q4 | 1.61 Million EUR | 355.35% |
2013 Q3 | 355.1 Thousand EUR | -57.18% |
2013 Q2 | 829.28 Thousand EUR | 133.53% |
2012 Q4 | 355.1 Thousand EUR | 53.88% |
2012 FY | 1.85 Million EUR | 146.49% |
2012 Q1 | 230.76 Thousand EUR | 0.0% |
2012 Q2 | 230.76 Thousand EUR | 0.0% |
2012 Q3 | 230.76 Thousand EUR | 0.0% |
2011 Q1 | 187.85 Thousand EUR | 0.0% |
2011 Q2 | 187.85 Thousand EUR | 0.0% |
2011 Q3 | 187.85 Thousand EUR | 0.0% |
2011 Q4 | 230.76 Thousand EUR | 22.84% |
2011 FY | 751.42 Thousand EUR | 22.46% |
2010 Q3 | 153.4 Thousand EUR | 0.0% |
2010 Q1 | 153.4 Thousand EUR | 0.0% |
2010 Q2 | 153.4 Thousand EUR | 0.0% |
2010 Q4 | 187.85 Thousand EUR | 22.46% |
2010 FY | 613.63 Thousand EUR | 42.9% |
2009 Q1 | 107.35 Thousand EUR | 0.0% |
2009 FY | 429.42 Thousand EUR | 0.0% |
2009 Q4 | 153.4 Thousand EUR | 42.9% |
2009 Q3 | 107.35 Thousand EUR | 0.0% |
2009 Q2 | 107.35 Thousand EUR | 0.0% |
2008 Q4 | 107.35 Thousand EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Predilife S.A. | 4.14 Million EUR | -1985.544% |
bioMĂ©rieux S.A. | 1.44 Billion EUR | 94.022% |
Eurofins Scientific SE | 73.6 Million EUR | -17.576% |
Lumibird SA | 115.93 Million EUR | 25.359% |